GlyCardial Diagnostics

Biotechnology Research • Barcelona, Catalonia, Spain • 1-10 Employees

Company overview

Headquarters	Baldiri Reixac 4-8, Tower I, Floor 5, A08, Barcelona, Barcelona 08028, ES
Website	glycardial.com
Keywords	Pharmaceutical, Medical Devices, Healthcare, Diagnostics, Cardiovascular Diseases, Ischemia
Founded	2017
Employees	1-10
Socials

Key Contact at GlyCardial Diagnostics

Juan-Carlos Kaski

Medical Director

About GlyCardial Diagnostics

GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event. GlyCardial Diagnostics was created by scientists Lina Badimon, Judit Cubedo, Teresa Padró and Gemma Vilahur. The company is located at the Hospital de la Santa Creu i Sant Pau Art Nouveau Site in Barcelona. In 2014, it was recognised as one of the most original, impactful technology projects in Spain in the MIT Technology Review awards for innovators under 35.

GlyCardial Diagnostics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	$2,200,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore GlyCardial Diagnostics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-02-08	9	$2,200,000

Funding Insights

$2,200,000

Total funding amount

$2,200,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

GlyCardial Diagnostics is located in Barcelona, Catalonia, ES.

GlyCardial Diagnostics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

GlyCardial Diagnostics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

GlyCardial Diagnostics has raised a total of $2,200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at GlyCardial Diagnostics

Juan-Carlos Kaski

Medical Director

4.8

40,000 users